Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) P/S ratio
As of 6 November 2026, Hinge Health Inc. (HNGE) trades at a P/S ratio of 12.7×. Over the past ten years it has ranged from 0.0× (June 2025) to 13.3× (November 2026); the current reading is higher than 99% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 4.3× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 9.1× | 94.07% |
| Mar 2026 | 4.7× | 8.76% |
| Dec 2025 | 4.3× | (42.31%) |
| Sep 2025 | 7.5× | 49.07% |
| 4 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 0.9× |
| PRVA Privia Health Group, Inc. compare | 1.2× |
| WAY Waystar Holding Corp. compare | 4.4× |
| HQY HealthEquity, Inc. compare | 6.3× |
| SDGR Schrodinger, Inc. compare | 8.1× |
| TEM Tempus AI, Inc. compare | 8.5× |
| DOCS Doximity, Inc. compare | 9.0× |
| HNGE Hinge Health Inc. | 12.7× |
| HTFL Heartflow, Inc. compare | 21.3× |
| Health Information Services industry median | 1.8× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement